Shares of Day One Biopharmaceuticals, Inc. (DAWN) have gained 2.2% over the past four weeks to close the last trading session at $12.13, but there could still be a solid upside left in the stock if ...
Hello, ladies and gentlemen, and welcome to the Day One Biopharmaceuticals Fourth Quarter and Full Year 2025 Financial and Operating Results Conference Call. [Operator Instructions] Please be advised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results